Industry leaders Dilip Shanghvi, Kiran Mazumdar-Shaw, and Glenn Saldanha call for sustained R&D investment and regulatory acceleration over critical next decade
This National Patient Safety Alert aims to reinforce good practice and raise awareness of steps that can help reduce risks while using patient hoists to transfer people
Lupin subsidiary VISUfarma will enjoy exclusive rights to undertake regulatory activities, commercialization, marketing, promotion, distribution and sale of Yuvezzi, an eye drop to treat presbyopia
Safety watchdog clarifies licensing pathways under Human Medicines Regulations 2012 to promote therapies for antimicrobial resistance and unmet clinical needs
